BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37156631)

  • 1. Selection of iPSCs without mtDNA deletion for autologous cell therapy in a patient with Pearson syndrome.
    Lee Y; Han J; Hwang SB; Kang SS; Son HB; Jin C; Kim JE; Lee BH; Kang E
    BMB Rep; 2023 Aug; 56(8):463-468. PubMed ID: 37156631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential amplification of a human mitochondrial DNA deletion in vitro and in vivo.
    Russell OM; Fruh I; Rai PK; Marcellin D; Doll T; Reeve A; Germain M; Bastien J; Rygiel KA; Cerino R; Sailer AW; Lako M; Taylor RW; Mueller M; Lightowlers RN; Turnbull DM; Helliwell SB
    Sci Rep; 2018 Jan; 8(1):1799. PubMed ID: 29379065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial genome mutations and neuronal dysfunction of induced pluripotent stem cells derived from patients with Alzheimer's disease.
    Lee Y; Kim M; Lee M; So S; Kang SS; Choi J; Kim D; Heo H; Lee SS; Park HR; Ko JJ; Song J; Kang E
    Cell Prolif; 2022 Jul; 55(7):e13274. PubMed ID: 35698260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De Novo Development of mtDNA Deletion Due to Decreased POLG and SSBP1 Expression in Humans.
    Lee Y; Kim T; Lee M; So S; Karagozlu MZ; Seo GH; Choi IH; Lee PCW; Kim CJ; Kang E; Lee BH
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33671400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysfunctional pancreatic cells differentiated from induced pluripotent stem cells with mitochondrial DNA mutations.
    So S; Lee S; Lee Y; Han J; Kang S; Choi J; Kim B; Kim D; Yoo HJ; Shim IK; Oh JY; Lee YN; Kim SC; Kang E
    BMB Rep; 2022 Sep; 55(9):453-458. PubMed ID: 35651332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS.
    Folmes CD; Martinez-Fernandez A; Perales-Clemente E; Li X; McDonald A; Oglesbee D; Hrstka SC; Perez-Terzic C; Terzic A; Nelson TJ
    Stem Cells; 2013 Jul; 31(7):1298-308. PubMed ID: 23553816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial genome mutations in mesenchymal stem cells derived from human dental induced pluripotent stem cells.
    Park J; Lee Y; Shin J; Lee HJ; Son YB; Park BW; Kim D; Rho GJ; Kang E
    BMB Rep; 2019 Dec; 52(12):689-694. PubMed ID: 31234953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human induced pluripotent stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell-like metabolic reprogramming.
    Prigione A; Lichtner B; Kuhl H; Struys EA; Wamelink M; Lehrach H; Ralser M; Timmermann B; Adjaye J
    Stem Cells; 2011 Sep; 29(9):1338-48. PubMed ID: 21732474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial single-stranded DNA binding protein novel de novo SSBP1 mutation in a child with single large-scale mtDNA deletion (SLSMD) clinically manifesting as Pearson, Kearns-Sayre, and Leigh syndromes.
    Gustafson MA; McCormick EM; Perera L; Longley MJ; Bai R; Kong J; Dulik M; Shen L; Goldstein AC; McCormack SE; Laskin BL; Leroy BP; Ortiz-Gonzalez XR; Ellington MG; Copeland WC; Falk MJ
    PLoS One; 2019; 14(9):e0221829. PubMed ID: 31479473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and Evaluation of Isogenic iPSC as a Source of Cell Replacement Therapies in Patients with Kearns Sayre Syndrome.
    Lester Sequiera G; Srivastava A; Alagarsamy KN; Rockman-Greenberg C; Dhingra S
    Cells; 2021 Mar; 10(3):. PubMed ID: 33807701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotent stem cells with a mitochondrial DNA deletion.
    Cherry AB; Gagne KE; McLoughlin EM; Baccei A; Gorman B; Hartung O; Miller JD; Zhang J; Zon RL; Ince TA; Neufeld EJ; Lerou PH; Fleming MD; Daley GQ; Agarwal S
    Stem Cells; 2013 Jul; 31(7):1287-97. PubMed ID: 23400930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suspension culture improves iPSC expansion and pluripotency phenotype.
    Cuesta-Gomez N; Verhoeff K; Dadheech N; Dang T; Jasra IT; de Leon MB; Pawlick R; Marfil-Garza B; Anwar P; Razavy H; Zapata-Morin PA; Jickling G; Thiesen A; O'Gorman D; Kallos MS; Shapiro AMJ
    Stem Cell Res Ther; 2023 Jun; 14(1):154. PubMed ID: 37280707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deoxyribonucleoside treatment rescues EtBr-induced mtDNA depletion in iPSC-derived neural stem cells with POLG mutations.
    Kristiansen CK; Furriol J; Chen A; Sullivan GJ; Bindoff LA; Liang KX
    FASEB J; 2023 Sep; 37(9):e23139. PubMed ID: 37584631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. iPSC culture expansion selects against putatively actionable mutations in the mitochondrial genome.
    Kosanke M; Davenport C; Szepes M; Wiehlmann L; Kohrn T; Dorda M; Gruber J; Menge K; Sievert M; Melchert A; Gruh I; Göhring G; Martin U
    Stem Cell Reports; 2021 Oct; 16(10):2488-2502. PubMed ID: 34560000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-Related Accumulation of Somatic Mitochondrial DNA Mutations in Adult-Derived Human iPSCs.
    Kang E; Wang X; Tippner-Hedges R; Ma H; Folmes CD; Gutierrez NM; Lee Y; Van Dyken C; Ahmed R; Li Y; Koski A; Hayama T; Luo S; Harding CO; Amato P; Jensen J; Battaglia D; Lee D; Wu D; Terzic A; Wolf DP; Huang T; Mitalipov S
    Cell Stem Cell; 2016 May; 18(5):625-36. PubMed ID: 27151456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive Clinical and Pathologic Features of Immature Teratomas Arising from Induced Pluripotent Stem Cell-Derived Beta Cell Injection in a Diabetes Patient.
    Han L; He H; Yang Y; Meng Q; Ye F; Chen G; Zhang J
    Stem Cells Dev; 2022 Mar; 31(5-6):97-101. PubMed ID: 35018826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Ethanol Extract of
    Kim A; Baek SJ; Shin S; Lee SY; Chung SK
    Nutrients; 2023 May; 15(10):. PubMed ID: 37242247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell reprogramming shapes the mitochondrial DNA landscape.
    Wei W; Gaffney DJ; Chinnery PF
    Nat Commun; 2021 Sep; 12(1):5241. PubMed ID: 34475388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the genic and metabolic characteristics of induced pluripotent stem cells from polycystic ovary syndrome women.
    Min Z; Gao Q; Zhen X; Fan Y; Tan T; Li R; Zhao Y; Yu Y
    Stem Cell Res Ther; 2018 Aug; 9(1):210. PubMed ID: 30092830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities.
    Wang XM; Yik WY; Zhang P; Lu W; Huang N; Kim BR; Shibata D; Zitting M; Chow RH; Moser AB; Steinberg SJ; Hacia JG
    Stem Cell Res Ther; 2015 Aug; 6():158. PubMed ID: 26319495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.